Is the combinational administration of doxorubicin and glutathione a reasonable proposal?

The down-regulation of SLC7A11 enhances ROS induced P-gp over-expression and drug resistance in MCF-7 breast cancer cells

(2017) Chun Ge et al.   Scientific Reports

Protective effect of 23-hydroxybetulinic acid on doxorubicin-induced cardiotoxicity: a correlation with the inhibition of carbonyl reductase-mediated metabolism

(2015) Fang Zhou et al.   BRITISH JOURNAL OF PHARMACOLOGY

Revisiting vitamin C and cancer

(2015) C. R. Reczek et al.   SCIENCE

Taurine zinc solid dispersions attenuate doxorubicin-induced hepatotoxicity and cardiotoxicity in rats

(2015) Yu Wang et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

The Promise and Perils of Antioxidants for Cancer Patients

(2014) Navdeep S. Chandel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Doxorubicin induces cell death in breast cancer cells regardless of Survivin and XIAP expression levels

(2013) Gabriela Nestal de Moraes et al.   EUROPEAN JOURNAL OF CELL BIOLOGY

Altered serum levels of IL-33 in patients with advanced systolic chronic heart failure: correlation with oxidative stress

(2012) Hai-Feng Zhang et al.   Journal of Translational Medicine

Combination decitabine, arsenic trioxide, and ascorbic acid for the treatment of myelodysplastic syndrome and acute myeloid leukemia: A phase I study

(2011) John S. Welch et al.   AMERICAN JOURNAL OF HEMATOLOGY

Genotoxic effects of doxorubicin in cultured human lymphocytes with different glutathione S-transferase genotypes

(2011) D.L. Ramos et al.   MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS

Effect of Vitamin C on Lipidperoxidation and Antioxidant Status in Tamoxifen-Treated Breast Cancer Patients

(2010) G. Muralikrishnan et al.   CHEMOTHERAPY

The Antioxidant Debate

(2010) Elena Ladas et al.   Explore-The Journal of Science and Healing